Researchers find combination can enhance ipilimumab immunotherapy

(University of Texas M. D. Anderson Cancer Center) Using a targeted therapy to block a protein that suppresses T cell activity could improve cancer treatment with immune checkpoint inhibitors, researchers at The University of Texas MD Anderson Cancer Center report today in the Journal of Clinical Investigation.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news